Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus
Open Access
- 1 April 2016
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 24 (4) , 671-677
Abstract
No abstract availableKeywords
Funding Information
- Poliomyelitis Research Foundation
- South African Medical Research Council
This publication has 47 references indexed in Scilit:
- Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector NucleasesMolecular Therapy, 2013
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineeringNature Biotechnology, 2013
- Predictors of Hepatitis B Cure Using Gene Therapy to Deliver DNA Cleavage Enzymes: A Mathematical Modeling ApproachPLOS Computational Biology, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Zinc-finger Nucleases as a Novel Therapeutic Strategy for Targeting Hepatitis B Virus DNAsMolecular Therapy, 2010
- Zinc Finger Proteins Designed To Specifically Target Duck Hepatitis B Virus Covalently Closed Circular DNA Inhibit Viral Transcription in Tissue CultureJournal of Virology, 2008
- Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patientsHepatology, 2006
- Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 HistonesGastroenterology, 2006
- Nuclear Covalently Closed Circular Viral Genomic DNA in the Liver of Hepatocyte Nuclear Factor 1α-Null Hepatitis B Virus Transgenic MiceJournal of Virology, 2001
- HEPATITIS B VIRUS CARRIER STATE IN BLACK CHILDREN IN OVAMBOLAND: ROLE OF PERINATAL AND HORIZONTAL INFECTIONThe Lancet, 1984